Filing Details

Accession Number:
0001209191-18-063579
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-19 19:07:47
Reporting Period:
2018-12-17
Accepted Time:
2018-12-19 19:07:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1269021 Portola Pharmaceuticals Inc PTLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192591 J Charles Homcy C/O Portola Pharmaceuticals, Inc.
270 East Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-17 64,218 $4.10 176,689 No 4 M Direct
Common Stock Disposition 2018-12-17 63,518 $18.60 113,171 No 4 S Direct
Common Stock Disposition 2018-12-17 700 $19.20 112,471 No 4 S Direct
Common Stock Acquisiton 2018-12-19 25,782 $4.10 119,480 No 4 M Indirect Charles Homcy Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Indirect Charles Homcy Revocable Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-12-17 24,390 $0.00 24,390 $4.10
Common Stock Stock Option (Right to Buy) Disposition 2018-12-17 39,828 $0.00 39,828 $4.10
Common Stock Stock Option (Right to Buy) Disposition 2018-12-19 25,782 $0.00 25,782 $4.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-12-23 2018-12-22 No 4 M Direct
25,782 2008-12-23 2018-12-22 No 4 M Direct
0 2008-12-23 2018-12-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect The Charles J. Homcy 2009 Grantor Retained Annuity Trust
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2018.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.2000 to $19.1900, inclusive.
  3. These sales were sold in a single transaction at a price of $19.20.
  4. Dr. Homcy exercised these shares through a cash exercise and transferred the shares following the exercise into the Charles Homcy Revocable Trust for which Dr. Homcy is a trustee.